Poznan University of Medical Sciences
The 12th of May 2022 saw the official opening of the University Clinical Trials Support Centre with an Early Phase Centre at the Medical University in Poznań. The UniCTSC carries out clinical trials using its own ambulatory care facility and the clinical resources of five subordinate clinical hospitals. The University is currently implementing the largest medical investment in Poland – the construction of Central Integrated Clinical Hospital which will also be used as a venue for clinical trials. The implementation of the UniCTSC will increase the number of clinical trials by ensuring, among other things: common standard operating procedures, quicker contract execution, common clinical trial resources, a systematised organisational structure, support given by coordinators to investigators, and joint data bases of medical records from all subordinate hospitals.
Principal advantages:
- A total of 141 research projects in 2021, including non-commercial clinical trials.
- All clinical trial phases, from phase 1 to post-marketing phase 4.
- Two departments dedicated to phase 1 research, including one specialising in oncology.
- Certified medical diagnostics laboratories (full range of services), a Genetic Laboratory, a University Device Centre (non-standard biomarker assays) and a Pharmaceutical Technology Transfer Centre with technical capabilities for pharmacodynamic, pharmacokinetics and bioavailability tests (phase 1 trials).
Website of the Clinical Trials Support Centre
Location: Marcelińska 42, 60-354 Poznan
Contact for Patients:
e-mail: badania.ucwbk@ump.edu.pl
tel.: (+48) 61 854 75 52
Contact for Sponsors/CRO:
Feasibility, e-mail: badania.ucwbk@ump.edu.pl, tel.: (+48) 61 854 75 52
Contracting, e-mail: ucwbk@ump.edu.pl, tel.: (+48) 508 455 229